New Combination Therapy for Resistant ER+ Breast Cancer

In preclinical studies, researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have tested a new combination therapy for hormone-resistant, estrogen receptor-positive (ER+)…

Continue ReadingNew Combination Therapy for Resistant ER+ Breast Cancer